Lifecore Biomedical, Inc. De (LFCR) Equity Average (2011 - 2025)

Lifecore Biomedical's Equity Average history runs 15 years deep, the most recent figure standing at $1.8 million for Q2 2025.

• In Q2 2025, Equity Average fell 87.71% year-over-year to $1.8 million; the TTM figure through May 2025 stood at $1.8 million (down 87.71% YoY), while the FY2025 annual figure was $6.3 million, up 78.56% from the prior year.
• Equity Average was $1.8 million for Q2 2025 at Lifecore Biomedical, down from $8.8 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $205.1 million in Q1 2021 to a low of -$8.9 million in Q3 2023.
• Historically, Equity Average has averaged $72.1 million across 5 years, with a median of $34.2 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Equity Average plunged 110.74% in 2023, then soared 194.82% in 2024.
• A 5-year view of Equity Average shows it stood at $174.3 million in 2021, then tumbled by 57.25% to $74.5 million in 2022, then sank by 108.15% to -$6.1 million in 2023, then jumped by 194.82% to $5.8 million in 2024, then tumbled by 69.03% to $1.8 million in 2025.
• The last three Equity Average figures came in at $1.8 million (Q2 2025), $8.8 million (Q1 2025), and $5.8 million (Q4 2024), per Business Quant data.